Agomab Therapeutics
Series CAgomab Therapeutics raised €95M in a Series C round in Oct 2023. The company is based in Ghent, Belgium. Investors in the round: Fidelity Management & Research Company LLC. Data as of Nov 2026.
Amount raised
€95M
€94,900,000
Native amount
94,900,000 EUR
Stage
Series C
series c
Investors
1
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €95M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
1 namedDate
Oct 2023
Round type
series c
Amount (EUR)
€95M